A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma

Publisher： John Wiley & Sons Inc

E-ISSN： 1878-0261|12|1|58-73

ISSN： 1574-7891

Source： Molecular Oncology, Vol.12, Iss.1, 2018-01, pp. : 58-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of the fibroblast growth factor receptor axis in cholangiocarcinoma

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 7, 2015-07 ,pp. : 1116-1122

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR-34a Expression, Cell Cycle Arrest and Cell Death of Malignant Mesothelioma Cells upon Treatment with Radiation, Docetaxel or Combination Treatment

By  

Oncology, Vol. 81, Iss. 5-6, 2012-01 ,pp. : 330-335

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23/Klotho Axis in Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 128, Iss. 1-2, 2014-11 ,pp. : 1-10

Karger

Access to resources Recommend Favorite

New approach for the treatment of neuropathic pain: Fibroblast growth factor 1 gene‐transfected adipose‐derived mesenchymal stem cells

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 22, Iss. 2, 2018-02 ,pp. : 295-310

John Wiley & Sons Inc

Access to resources Recommend Favorite

Decreased serum miR-181a is a potential new tool for breast cancer screening

By    

International Journal of Molecular Medicine, Vol. 30, Iss. 3, 2012-01 ,pp. : 680-686

Spandidos Publications

Access to resources Recommend Favorite